Deyali Chatterjee

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Deyali Chatterjee is an Associate Professor at The University of Texas MD Anderson Cancer Center, USA. Her research areas include prostate cancer biomarkers, pancreatic ductal adenocarcinoma treatment outcomes, and colorectal cancer characteristics. She has contributed to recent studies focusing on the clinical and pathological features of cancer, particularly in the context of neoadjuvant therapies and survival predictors.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Dan Zhao

Assistant professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Eugene J. Koay

UNITED STATES

View details

Ching‐Wei D. Tzeng

UNITED STATES

View details

Matthew H. G. Katz

UNITED STATES

View details

Anirban Maitra

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Joseph E Ippolito

Washington University School of Medicine

UNITED STATES

View details

Anup Shetty

Associate Professor of Radiology

Washington University in St Louis School of Medicine Mallinckrodt Institute of Radiology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Deyali Chatterjee

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype

The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients

The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.

Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning

Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity

Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer

Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma

Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence‐free survival in stages I–III colorectal cancer

Poorly formed hepatic granulomas: a rare manifestation of acute T cell‐mediated rejection

Collaborators (7)

Dan Zhao

Eugene J. Koay

Ching‐Wei D. Tzeng

Matthew H. G. Katz

Anirban Maitra

Joseph E Ippolito

Anup Shetty

Make your next move.

Deyali Chatterjee

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype

The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients

The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.

Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning﻿

Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity

Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer

Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma

Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence‐free survival in stages I–III colorectal cancer

Poorly formed hepatic granulomas: a rare manifestation of acute T cell‐mediated rejection

Collaborators (7)

Dan Zhao

Eugene J. Koay

Ching‐Wei D. Tzeng

Matthew H. G. Katz

Anirban Maitra

Joseph E Ippolito

Anup Shetty

Make your next move.

Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning